LWANC
BNTX icon

Laurel Wealth Advisors (North Carolina)’s BioNTech BNTX Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$752 – 600
2022
Q4 		$752 Hold
5
– – ﹤0.01% 512
2022
Q3 		$1K Sell
5
-20
-80% -$3.06K ﹤0.01% 504
2022
Q2 		$4K Buy
25
+5
+25% +$764 ﹤0.01% 460
2022
Q1 		$3K Hold
20
– – ﹤0.01% 529
2021
Q4 		$5K Hold
20
– – ﹤0.01% 477
2021
Q3 		$5K Hold
20
– – ﹤0.01% 468
2021
Q2 		$4K Buy
+20
New +$3.77K ﹤0.01% 562

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s BNTX Position: Q1 2023 in Review

Laurel Wealth Advisors (North Carolina) sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 5 shares — an estimated $752 sold.

Laurel Wealth Advisors (North Carolina) first reported a position in BNTX in Q2 2021 and held it in 7 quarters. The position peaked at $5K in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Laurel Wealth Advisors (North Carolina) reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 5 BioNTech shares in Q1 2023, an estimated $752.
  • Laurel Wealth Advisors (North Carolina) first reported a position in BioNTech in Q2 2021 and held it in 7 quarters.
  • Laurel Wealth Advisors (North Carolina)'s BioNTech position peaked at $5K in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2023, filed 8 May 2023.